Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Crohn Disease
|
1147 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.850 | 1.000 | 7 | 2006 | 2020 | |||||
Rheumatoid Arthritis
|
2387 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.050 | 0.800 | 5 | 2008 | 2018 | |||||
Myocardial Infarction
|
680 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1 | 2008 | 2008 | ||||||
Thyroid associated opthalmopathies
|
49 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Ankylosing spondylitis
|
609 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.030 | 0.667 | 3 | 2009 | 2018 | |||||
Ulcerative Colitis
|
827 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.820 | 1.000 | 3 | 2009 | 2020 | |||||
Cardiomyopathy, Familial Idiopathic
|
243 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Sjogren's Syndrome
|
47 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.020 | 1.000 | 2 | 2010 | 2013 | |||||
Malignant neoplasm of stomach
|
615 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.030 | 1.000 | 3 | 2011 | 2019 | |||||
Stomach Carcinoma
|
652 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.030 | 1.000 | 3 | 2011 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.030 | 1.000 | 3 | 2012 | 2015 | |||||
Malignant neoplasm of breast
|
3417 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.030 | 1.000 | 3 | 2012 | 2015 | |||||
Malignant Neoplasms
|
1641 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.030 | 0.667 | 3 | 2012 | 2015 | |||||
Primary malignant neoplasm
|
1374 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.030 | 0.667 | 3 | 2012 | 2015 | |||||
Carcinoma of lung
|
1204 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Lip and Oral Cavity Carcinoma
|
172 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of lung
|
1142 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of mouth
|
184 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Nasopharyngeal carcinoma
|
320 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Neoplasms
|
1644 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Primary malignant neoplasm of lung
|
981 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Secondary malignant neoplasm of lymph node
|
188 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1 | 2013 | 2013 | ||||||
Immune thrombocytopenic purpura
|
35 | 0.627 | 0.720 | 1 | 67259437 | 3 prime UTR variant | C/A | snv | 0.27 | 0.010 | 1.000 | 1 | 2013 | 2013 |